TrialJournal of neuro-oncology2018

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.

Arif N Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.